share_log

Ascendiant Capital Initiates Coverage On Cyclo Therapeutics With Buy Rating, Announces Price Target of $2.6

Ascendiant Capital Initiates Coverage On Cyclo Therapeutics With Buy Rating, Announces Price Target of $2.6

Ascendiant Capital以买入评级启动对Cyclo Therapeutics的报道,宣布目标股价为2.6美元
Moomoo 24/7 ·  04/22 05:40

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces Price Target of $2.6.

Ascendiant Capital分析师卢卡斯·沃德开始对Cyclo Therapeutics(纳斯达克股票代码:CYTH)进行报道,评级为买入,并宣布目标股价为2.6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发